Montelukast Sodium Tablet, Chewable
Product Images NDC 63187-751

4 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 63187-751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure_01 (Montelukast Fig1)

Figure_01 (Montelukast Fig1)
A line graph illustrating change in height (cm) over weeks on treatment for three groups: Montelukast sodium chewable tablets 5 mg, Beclomethasone 336 mcg, and Placebo. The x-axis shows weeks from -19 to 56, and the y-axis shows height change ranging from -3 to 7 cm. Each treatment group's mean height change trends upwards over time with small standard errors not visible on the plot.*
FDA Label Image

Figure_2 (Montelukast Fig2)

Figure_2 (Montelukast Fig2)
A line graph showing mean percent change from baseline over weeks in treatment and washout periods. The X-axis represents weeks in treatment, including a washout period at week 13, while the Y-axis shows mean percent change. Two lines are plotted: one for Montelukast sodium tablet (solid circles) and one for placebo (open squares), illustrating differences in effects over time.*
FDA Label Image

Structure (Montelukast Str)

Structure (Montelukast Str)
Chemical structure diagram of Montelukast Sodium, showing the molecular arrangement of the active ingredient depicted in a labeled two-dimensional format.*
FDA Label Image

63187-751-30 (Montelukast 4mg 90)

63187-751-30 (Montelukast 4mg 90)
Label for Montelukast Sodium 4 mg chewable tablets by Proficient Rx LP. The label states the product is for pediatric patients aged 2-5 years and each tablet contains 4.2 mg Montelukast Sodium USP equivalent to 4 mg Montelukast. It includes storage instructions and manufacturer information from Ajanta Pharma USA Inc., Bridgewater, NJ. Multiple small label copies with lot and expiration placeholders are shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.